Journal Club 2026

Next HOPA Journal Club

Thursday, April 16, 2026 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Orange button that says click here to register

The moderator for April's Journal Club session is:

Francis De Los Reyes, PharmD, NYU Langone Health, New York, NY

April's Journal Club presenters include:

Cassondra Capezza, PharmD

PGY2 Oncology Pharmacy Resident

Dartmouth-Hitchcock Medical Center, Lebanon, NH

Article:

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Meera Patel, PharmD

PGY2 Oncology Pharmacy Resident

UW Health, Madison, WI

Article:

Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer

Featured Articles

HOPA News

Late-Breaking HOPA News: Redefining Relapse: What MajesTEC-3 Means for the Treatment of Multiple Myeloma

March 17, 2026

Sanja Zepcan, PharmD, BCPS, BCOP, and Emily Rux, PharmD, BCOP, discuss the clinical questions raised by the recent MajesTEC-3 trial and the potential changes it finds in the treatment of multiple myeloma.

An image of chronic lymphocytic leukemia cells under a microscope

Tools and Resources

Pharmacist's Application to Practice: Pirtobrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

March 03, 2026

Cristina V. Martinez, PharmD, PGY2 Oncology Pharmacy Resident, and Hunter Sowell, PharmD, BCOP, Clinical Pharmacy Specialist Oncology, analyze the potential role for pirtobrutinib in treating chronic lymphocytic leukemia and small lymphocytic lymphoma.

Collaborations

Pharmacy Students and Oncology Pharmacists Combat Cancer Misinformation with National Initiative

February 24, 2026

The Hematology/Oncology Pharmacy Association (HOPA) is proud to team up with the Student National Pharmaceutical Association (SNPhA) for the Cancer Clarity Challenge, a new national competition.